Physician profile
Macy Stapleton
NPI 1538442694
$750.99
in general payments reported to CMS, 2019-2025
13 companies · $132 in 2025
The $132 reported for 2025 was more than what a typical Pediatrics (Nurse Practitioner) provider received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $131 · 2022: $160 · 2023: $142 · 2024: $187 · 2025: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $460.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $460.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $124.63 | 2021-2023 | |
| Glaxosmithkline, LLC. | $112.47 | 2021-2025 | Bexsero, Pediarix |
| Merck Sharp & Dohme LLC | $101.47 | 2023-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Supernus Pharmaceuticals, INC. | $96.92 | 2023-2024 | Qelbree, Qelbree |
| Corium, LLC | $63.57 | 2022-2023 | Azstarys |
| Seqirus USA INC | $61.38 | 2021-2025 | Flucelvax |
| Ironshore Pharmaceuticals INC. | $43.45 | 2024 | |
| Sanofi Pasteur INC. | $36.91 | 2022-2024 | |
| Sanofi-Aventis U.S. LLC | $32.03 | 2024 | |
| Ars Pharmaceuticals Operations, INC. | $26.05 | 2025 | Neffy |
| Cranial Technologies, INC | $23.05 | 2023 | Doc Band |
| Galderma Laboratories, L.P. | $15.46 | 2021 | |
| Cognoa, INC. | $13.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Macy Stapleton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.